Get 20% off on Global Market Reports until March 31st! Use code FY25SAVE at checkout.

How has the tepezza market grown over the years?

In the recent past, the market size for tepezza has experienced a XX (HCAGR). It is projected to increase from $XX million in 2024 to $XX million in 2025, with a compound annual growth rate (CAGR) of XX%. The expansion during the previous era can be tied to factors such as the rising occurrence of thyroid eye disease, the FDA’s authorization for TED treatment, the inadequate options for TED treatment, a significant demand for effective therapies, strides made in biologic drug development, and an increase in awareness and diagnosis of TED.

What Is the forecasted market size and growth rate for the tepezza market?

An increase in the tepezza market size is anticipated in the coming few years, with a forecasted compound annual growth rate (CAGR) of XX%. It is projected to reach a value of $XX million by 2029. Driving this growth could be factors such as an increase in the elderly population, expansion into new global markets, a higher number of thyroid disorders, progress in personalized treatments, and the widespread use of biologic therapies. Additionally, the trend is shifting towards home-based care, innovative methods of administration, combined treatments for TED, a growing emphasis on precision medicine, and the implementation of artificial intelligence in treatment planning.

Get your tepezza market report here!

https://www.thebusinessresearchcompany.com/report/tepezza-global-market-report

What are the major factors driving growth in the tepezza market?

The rising prevalence of thyroid disorders is anticipated to fuel the expansion of the tepezza market. Thyroid conditions encompass a variety of ailments that impair the formation or operation of the thyroid gland, a butterfly-like gland situated in the neck. The surge in thyroid diseases can be traced back to a variety of factors, chiefly enhanced diagnostic methodologies such as high-definition ultrasound and fine-needle aspiration facilitating early detection of thyroid anomalies. Tepezza (teprotumumab) serves as a treatment for thyroid eye disease by blocking the insulin-like growth factor-1 receptor (IGF-1R), thereby decreasing the inflammation, swelling, and proptosis within the surrounding eye area. For instance, the National Institutes of Health, an American governmental body, projected in July 2022 that thyroid cancer was expected to constitute the 13th most routinely diagnosed form of cancer in 2022 in the US, accounting for around 44,000 new cases or 2.3% of all diagnosed cancers. Thus, the escalating occurrence of thyroid disorders is propelling the tepezza market’s growth.

What key areas define the segmentation of the global tepezza Market?

The tepezza market covered in this report is segmented –

1) By Clinical Indication: Thyroid Eye Disease (TED); Orbital Inflammatory Diseases; Inflammatory Ocular Conditions

2) By Route Of Administration: Intravenous; Subcutaneous

3) By Distribution Channel: Hospital Pharmacies; Online Pharmacies

4) By End User: Adult; Geriatric

Get your free sample now – explore exclusive market insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=20365&type=smp

What are the top market players propelling the growth of the tepezza industry?

Major companies operating in the tepezza market are Amgen Inc.

What are the key trends shaping the future of the tepezza market?

The prominent trend in the tepezza (teprotumumab-trbw) market is the pursuit of regulatory clearances to broaden its usage beyond Thyroid Eye Disease (TED). Regulatory clearances involve official confirmation from health organizations that a drug is safe, effective, and of high quality for certain medical applications. For example, in April 2023, Horizon Therapeutics plc, an Irish biotech firm, shared news of the FDA’s approval to revise the indication terminology for TEPEZZA (teprotumumab-trbw), making it applicable for patients with Thyroid Eye Disease (TED) regardless of the disease’s activity or duration. This vital amendment increases availability of treatment for all suitable TED patients, as TEPEZZA is the only medication specifically authorized by the FDA for this ailment. The authorization is backed by information from a Phase 4 clinical trial showcasing the effectiveness of TEPEZZA in minimizing eye protrusion in patients suffering from prolonged TED. Tim Walbert, the CEO of Horizon, noted that this modification serves to enhance early access to treatment, eventually improving patient outcomes.

Unlock exclusive market insights – purchase your research report now for a swift delivery!

https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=20365

What regions are dominating the tepezza market growth?

North America was the largest region in the tepezza market in 2024. The regions covered in the tepezza market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Browse Through More Similar Reports By The Business Research Company:

Global Insulin Pens, Syringes, Pumps And Injectors Opportunities And Strategies Global Market Report 2025

https://thebusinessresearchcompany.com/report/insulin-pens-syringes-pumps-and-injectors-market

Parathyroid Hormone Global Market Report 2025

https://thebusinessresearchcompany.com/report/parathyroid-hormones-global-market-report

Smart Insulin Pens Global Market Report 2025

https://thebusinessresearchcompany.com/report/smart-insulin-pens-global-market-report

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Contact us at:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 3156230293

Asia +44 2071930708

Europe +44 2071930708

Email us at [email protected]

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Found this article helpful? Share it on: